Cargando…

Biomimetic nanoplasmonic sensor for rapid evaluation of neutralizing SARS-CoV-2 monoclonal antibodies as antiviral therapy

Monoclonal antibody (mAb) therapy is one of the most promising immunotherapies that have shown the potential to prevent or neutralize the effects of COVID-19 in patients at very early stages, with a few formulations recently approved by the European and American medicine agencies. However, a main bo...

Descripción completa

Detalles Bibliográficos
Autores principales: Batool, Razia, Soler, Maria, Colavita, Francesca, Fabeni, Lavinia, Matusali, Giulia, Lechuga, Laura M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier B.V. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9904857/
https://www.ncbi.nlm.nih.gov/pubmed/36796306
http://dx.doi.org/10.1016/j.bios.2023.115137